Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

19%

4 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (8)
P 1 (1)
P 3 (1)
P 4 (3)

Trial Status

Completed14
Unknown6
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT06508944Phase 4Completed

Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women

NCT06814847Completed

Artificial Intelligence-Based Analysis of Uroflowmetry Patterns in Children: a Machine Learning Perspective

NCT05941260Completed

Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics

NCT06070675Not ApplicableRecruiting

Comparison of a Paper and Automated Bladder Diary in Pediatric Patients

NCT05295823Not ApplicableCompletedPrimary

Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound

NCT05537272Phase 4Unknown

The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy

NCT03991429CompletedPrimary

Brain Imaging in Men With Lower Urinary Tract Symptoms

NCT03373773Not ApplicableCompletedPrimary

Home vs. Office Foley Catheter Removal in Women With Voiding Difficulty Following Pelvic Reconstructive Surgery

NCT05490082Phase 3UnknownPrimary

Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation

NCT04570605Not ApplicableCompleted

Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population

NCT05240456Phase 1UnknownPrimary

Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children

NCT05182853Completed

Voiding Disorders in Children After Sacrococcygeal Teratoma Resection

NCT04010656Not ApplicableUnknown

Optimization of Spontaneous Postoperative Trial of Void Among Women

NCT04928716Completed

Multiple Sclerosis and Voiding Symptoms: How to Assess?

NCT03631160Not ApplicableCompletedPrimary

Effect of Transcutaneous Acupoint Electrical Stimulation on Postoperative Spontaneous Voiding for Laparoscopic Patients

NCT04429360Unknown

What is the Effect of Prolapse Surgery on Voiding?

NCT04184752CompletedPrimary

Prevalence of Detrusor Underactivity and Bladder Outlet Obstruction in Female Without Cystocele

NCT04064619Not ApplicableCompletedPrimary

Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms

NCT03390790Phase 4CompletedPrimary

Lidocaine for Pain After Urodynamic Testing

NCT03293771Unknown

Transgender Post-reassignment Urogynecologic Measures and Perceptions

Scroll to load more

Research Network

Activity Timeline